| CTRI Number |
CTRI/2020/12/030039 [Registered on: 24/12/2020] Trial Registered Prospectively |
| Last Modified On: |
13/12/2021 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Other |
|
Public Title of Study
|
To compare the effect of prophylactic infusion of intravenous phenylephrine, nor epinephrine and mephentermine for maintenance of blood pressure in patients undergoing elective caesarean section under spinal anesthesia |
|
Scientific Title of Study
|
TO COMPARE THE EFFECT OF INFUSION DOSES OF INTRAVENOUS PHENYLEPHRINE, NOREPINEPHRINE AND MEPHENTERMINE FOR MAINTENANCE OF BLOOD PRESSURE DURING SPINAL ANAESTHESIA IN CAESAREAN SECTION AND THEIR EFFECTS ON NEONATE. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Rasulata swain |
| Designation |
Post-graduate 1st year |
| Affiliation |
KIMS |
| Address |
Department of Anaesthesiology KIMS,Bhubaneswar
Khordha ORISSA 751024 India |
| Phone |
9078467966 |
| Fax |
|
| Email |
drrasuswain@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DrBrig Ganesh Chandra Satapathy |
| Designation |
Professor and Head of Department( Anaesthesiology) |
| Affiliation |
KIMS |
| Address |
Department of Anaesthesiology KIMS,Bhubaneswar
Khordha ORISSA 751024 India |
| Phone |
8283872939 |
| Fax |
|
| Email |
ganesh.satapathy@kims.ac.in |
|
Details of Contact Person Public Query
|
| Name |
DR BRIG GANESH CHANDRA SATAPATHY |
| Designation |
Professor and Head of Department( Anaesthesiology) |
| Affiliation |
KIMS |
| Address |
Department of Anaesthesiology KIMS,Bhubaneswar
Khordha ORISSA 751024 India |
| Phone |
8283872939 |
| Fax |
|
| Email |
ganesh.satapathy@kims.ac.in |
|
|
Source of Monetary or Material Support
|
| rasulata swain
kalinga institute of medical sciences |
|
|
Primary Sponsor
|
| Name |
kalinga institute of medical sciences |
| Address |
kalinga institute of medical sciences,campus-5,kiit road,patia,bhubneswar,odisha |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| rasulata swain |
kalinga institute of medical sciences |
1rd floor,department of obstetrics and gynecology Khordha ORISSA |
9078467966
drrasuswain@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| institutional ethics committee,kims |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O00-O9A||Pregnancy, childbirth and the puerperium, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
phenylephrine |
Patients will be randomized into three groups
→ Group P- will receive infusion phenylephrine 50mcg/ml @ 0.1mcg/kg/min
→ Group N- will receive infusion norepinephrine @ 0.05mcg/kg/min
→ Group M- will receive infusion mephentermine @ 3mg/min
|
| Comparator Agent |
MEPHENTERAMINE |
Patients will be randomized into three groups → Group P- will receive infusion phenylephrine 50mcg/ml @ 0.1mcg/kg/min → Group N- will receive infusion norepinephrine @ 0.05mcg/kg/min → Group M- will receive infusion mephentermine @ 3mg/min |
| Comparator Agent |
NOREPINEPHRINE |
Patients will be randomized into three groups → Group P- will receive infusion phenylephrine 50mcg/ml @ 0.1mcg/kg/min → Group N- will receive infusion norepinephrine @ 0.05mcg/kg/min → Group M- will receive infusion mephentermine @ 3mg/min |
|
|
Inclusion Criteria
|
| Age From |
21.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Female |
| Details |
1. Age 21-40 years
2. ASA II
3. Singleton term pregnancy
4. Elective caesarean section
5. Parturient with no co-morbidity
|
|
| ExclusionCriteria |
| Details |
1. Pre-existing pregnancy-induced
hypertension
2. Cardiovascular disease
3. Hepato-renal disease
4. Use of cardiac medication or medication
for blood pressure control
5. Gestational diabetes mellitus requiring
insulin
6. Suspicion of abnormal placentation
7. Allergy to study drugs
8. Intraoperative use of uterotonic other
than oxytocin
9. Known fetal abnormality
10. Contraindication to subarachnoid block
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| • To compare the effect of prophylactic infusion of intravenous phenylephrine, nor epinephrine and mephentermine for maintenance of blood pressure in patients undergoing elective caesarean section under spinal anesthesia . |
Blood pressure and heart rate recorded every 2 minutes until delivery. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
Incidence of bradycardia,hypertension,hypotension.
-Total doses of rescue drug required.
-Neonatal APGAR scores at 1 and 5 minutes.
-To find the incidence of post operative nausea and vomiting.
|
Blood pressure and heart rate recorded every 2 minutes until delivery. |
|
|
Target Sample Size
|
Total Sample Size="240" Sample Size from India="240"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
01/01/2021 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
not yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The technique of choice for
anaesthesia in caesarean section, is subarachnoid block. However, this
technique is known to cause hypotension, i.e., fall in blood pressure more than
20% from the baseline. Such fall in blood pressure can have deleterious effects
on both the mother and the baby in utero. The incidence of maternal hypotension
can be as high as 70- 85% if pharmacological prophylaxis isn’t used. When
maternal hypotension is recognized and treated promptly, the maternal and fetal
morbidity is decreased significantly. Hence, in our study, we are comparing
three vasopressor agents, viz., Phenylephrine, Noradrenaline, and
Mephentermine, so as to determine the best pharmacological agent to prevent
maternal hypotension in parturients undergoing caesarean section under spinal
anaesthesia. The patients who match our inclusion and exclusion criteria, and
those who give a valid written informed consent, shall be divided into three
groups, each receiving one of the three vasopressor agents if they develop
hypotension following spinal anaesthesia. We shall be observing the incidence
and magnitude of maternal hypotension following spinal anaesthesia. We shall
also be documenting the incidence of, as well as the magnitude of decrease in
fall in BP , the amount of drug dosages of each vasopressor agent required for
the same, neonatal APGAR scores at 1 minute and 5 minutes, and the incidence of
maternal post-operative nausea and vomiting. |